Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yongjun Yin

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Polymers|April 12, 2025
Photothermal Catalysis of Cellulose to Prepare Levulinic Acid-Rich Bio-OilBolun Li, Mengyan Wang, Huixiang Luo, et al.
Biorxiv : the Preprint Server for Biology|July 14, 2025
Latent transforming growth factor binding protein-2 (LTBP2), an IPF biomarker of clinical decline, promotes TGF-beta signaling and lung fibrosis in miceNicholas K Bodmer, Malay Choudhury, Haider Mirza, et al.
Plos Genetics|May 16, 2015
Fibroblast Growth Factor 9 Regulation by MicroRNAs Controls Lung Development and Links DICER1 Loss to the Pathogenesis of Pleuropulmonary BlastomaYongjun Yin, Angela M Castro, Marrit Hoekstra, et al.
American Journal of Respiratory Cell and Molecular Biology|June 3, 2026
Latent transforming growth factor binding protein-2 (LTBP2), an IPF biomarker of clinical decline, promotes TGF-beta signaling and lung fibrosis in miceNicholas K Bodmer, Malay Choudhury, Haider Mirza, et al.
The Journal of Pathology|November 22, 2014
Characterization of the cell of origin and propagation potential of the fibroblast growth factor 9-induced mouse model of lung adenocarcinomaDaisuke Arai, Ahmed E Hegab, Kenzo Soejima, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 22, 2024
Notoginsenoside R1 treatment facilitated Nrf2 nuclear translocation to suppress ferroptosis via Keap1/Nrf2 signaling pathway to alleviated high-altitude myocardial injuryYilan Wang, Yongjun Yin, Ying Liu, et al.
The Journal of Pathology|May 16, 2019
Effect of FGF/FGFR pathway blocking on lung adenocarcinoma and its cancer-associated fibroblastsAhmed E Hegab, Mari Ozaki, Naofumi Kameyama, et al.
Disease Models & Mechanisms|April 9, 2016
Inhibition of fibroblast growth factor receptor 3-dependent lung adenocarcinoma with a human monoclonal antibodyYongjun Yin, Xiaodi Ren, Craig Smith, et al.
Lung Cancer (Amsterdam, Netherlands)|April 17, 2018
Tumor associated macrophages support the growth of FGF9-induced lung adenocarcinoma by multiple mechanismsAhmed E Hegab, Mari Ozaki, Shizuko Kagawa, et al.
Plos Pathogens|June 8, 2022
Fibroblast growth factor-9 expression in airway epithelial cells amplifies the type I interferon response and alters influenza A virus pathogenesisBradley E Hiller, Yongjun Yin, Yi-Chieh Perng, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Polymers|April 12, 2025
Photothermal Catalysis of Cellulose to Prepare Levulinic Acid-Rich Bio-OilBolun Li, Mengyan Wang, Huixiang Luo, et al.
Biorxiv : the Preprint Server for Biology|July 14, 2025
Latent transforming growth factor binding protein-2 (LTBP2), an IPF biomarker of clinical decline, promotes TGF-beta signaling and lung fibrosis in miceNicholas K Bodmer, Malay Choudhury, Haider Mirza, et al.
Plos Genetics|May 16, 2015
Fibroblast Growth Factor 9 Regulation by MicroRNAs Controls Lung Development and Links DICER1 Loss to the Pathogenesis of Pleuropulmonary BlastomaYongjun Yin, Angela M Castro, Marrit Hoekstra, et al.
American Journal of Respiratory Cell and Molecular Biology|June 3, 2026
Latent transforming growth factor binding protein-2 (LTBP2), an IPF biomarker of clinical decline, promotes TGF-beta signaling and lung fibrosis in miceNicholas K Bodmer, Malay Choudhury, Haider Mirza, et al.
The Journal of Pathology|November 22, 2014
Characterization of the cell of origin and propagation potential of the fibroblast growth factor 9-induced mouse model of lung adenocarcinomaDaisuke Arai, Ahmed E Hegab, Kenzo Soejima, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 22, 2024
Notoginsenoside R1 treatment facilitated Nrf2 nuclear translocation to suppress ferroptosis via Keap1/Nrf2 signaling pathway to alleviated high-altitude myocardial injuryYilan Wang, Yongjun Yin, Ying Liu, et al.
The Journal of Pathology|May 16, 2019
Effect of FGF/FGFR pathway blocking on lung adenocarcinoma and its cancer-associated fibroblastsAhmed E Hegab, Mari Ozaki, Naofumi Kameyama, et al.
Disease Models & Mechanisms|April 9, 2016
Inhibition of fibroblast growth factor receptor 3-dependent lung adenocarcinoma with a human monoclonal antibodyYongjun Yin, Xiaodi Ren, Craig Smith, et al.
Lung Cancer (Amsterdam, Netherlands)|April 17, 2018
Tumor associated macrophages support the growth of FGF9-induced lung adenocarcinoma by multiple mechanismsAhmed E Hegab, Mari Ozaki, Shizuko Kagawa, et al.
Plos Pathogens|June 8, 2022
Fibroblast growth factor-9 expression in airway epithelial cells amplifies the type I interferon response and alters influenza A virus pathogenesisBradley E Hiller, Yongjun Yin, Yi-Chieh Perng, et al.
Pageof 3